Kentucky Bioprocessing Selects Meridian Clinical Research to Conduct Phase I Influenza Vaccine Clinical Trial of KBP-V001

Kentucky Bioprocessing (KBP) (owned by British American Tobacco) recently launched a clinical trial to test its seasonal flu vaccine candidate. Working with research site organization Meridian Clinical Research, the sponsor and principal investigator will be...

Scripps Research and Others Pursuing a Cure for the Flu

Influenza doesn’t go just away. It killed 80,000 last year in the United States reported Stat. Although single vaccines exist to prevent measles and smallpox, nothing helps prevent flu permanently. To beat the flu we need a different vaccine each year and it isn’t a...

Pin It on Pinterest